Use promo code GOBLUE to receive an exclusive discount

Genomic Test Could Help Predict Aggressive Disease in Men Newly Diagnosed with Prostate Cancer

July 27, 2021

 • 

Read time:

5-15 mins
Share on facebook
Share on twitter
Share on reddit
Share on email
Share on print
Microscopic Cell Prostate Cancer Teal Gatewayextension
Share on facebook
Share on twitter
Share on reddit
Share on email
Share on print
Presented by Health Lab

People who are diagnosed with prostate cancer face a choice between a watch-and-wait approach versus surgery or radiation. It can also be difficult to figure out who will benefit from more immediate and aggressive treatment. A U-M study found that a commercially available genomic test known as Decipher Biopsy might identify patients at a higher risk of cancer progression.

More from the Alumni Education Gateway
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.